Pharmacological inhibition of p110δ subunit of PI3K confers protection against experimental leishmaniasis
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pharmacological inhibition of p110δ subunit of PI3K confers protection against experimental leishmaniasis
Authors
Keywords
-
Journal
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Volume 72, Issue 2, Pages 467-477
Publisher
Oxford University Press (OUP)
Online
2016-09-30
DOI
10.1093/jac/dkw448
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Innate Immune B Cell Activation by Leishmania donovani Exacerbates Disease and Mediates Hypergammaglobulinemia
- (2016) Sasha Silva-Barrios et al. Cell Reports
- Effect of Cocaine on HIV Infection and Inflammasome Gene Expression Profile in HIV Infected Macrophages
- (2016) Venkata Subba Rao Atluri et al. Scientific Reports
- PI3K isoform-selective inhibitors: next-generation targeted cancer therapies
- (2015) Xiang Wang et al. ACTA PHARMACOLOGICA SINICA
- Idelalisib-associated Colitis
- (2015) Anna-Sophie Weidner et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Amphotericin B Formulations and Other Drugs for Visceral Leishmaniasis
- (2015) Jonathan Berman AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- Idelalisib: First-in-Class PI3K Delta Inhibitor for the Treatment of Chronic Lymphocytic Leukemia, Small Lymphocytic Leukemia, and Follicular Lymphoma
- (2015) Q. Yang et al. CLINICAL CANCER RESEARCH
- Clinical Pharmacokinetic and Pharmacodynamic Profile of Idelalisib
- (2015) Srinivasan Ramanathan et al. CLINICAL PHARMACOKINETICS
- Drugging PI3K in cancer: refining targets and therapeutic strategies
- (2015) Timothy A Yap et al. CURRENT OPINION IN PHARMACOLOGY
- Leishmaniasis: diagnostic issues in Europe
- (2015) Paul Torpiano et al. Expert Review of Anti-Infective Therapy
- Hepatic stellate cells regulate liver immunity to visceral leishmaniasis through P110δ-dependent induction and expansion of regulatory T cells in mice
- (2015) Forough Khadem et al. HEPATOLOGY
- Profound blockade of T cell activation requires concomitant inhibition of different class I PI3K isoforms
- (2015) Belén Blanco et al. IMMUNOLOGIC RESEARCH
- Leishmaniasis
- (2015) Esther Von Stebut JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT
- Phosphoinositide 3-kinase β, phosphoinositide 3-kinase δ, and phosphoinositide 3-kinase γ mediate the anti-inflammatory effects of magnesium sulfate
- (2015) Ping-Ying Lee et al. JOURNAL OF SURGICAL RESEARCH
- New delivery systems for amphotericin B applied to the improvement of leishmaniasis treatment
- (2015) Miguel Angel Chávez-Fumagalli et al. Revista da Sociedade Brasileira de Medicina Tropical
- Health Economic Evaluations of Visceral Leishmaniasis Treatments: A Systematic Review
- (2015) Daniel S. Marinho et al. PLoS Neglected Tropical Diseases
- Idelalisib: First Global Approval
- (2014) Anthony Markham DRUGS
- An update on pharmacotherapy for leishmaniasis
- (2014) Shyam Sundar et al. EXPERT OPINION ON PHARMACOTHERAPY
- Cross-species Proteomics Reveals Specific Modulation of Signaling in Cancer and Stromal Cells by Phosphoinositide 3-kinase (PI3K) Inhibitors
- (2014) Vinothini Rajeeve et al. MOLECULAR & CELLULAR PROTEOMICS
- PI3Kδ Inhibition by Idelalisib in Patients with Relapsed Indolent Lymphoma
- (2014) Ajay K. Gopal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Idelalisib and Rituximab in Relapsed Chronic Lymphocytic Leukemia
- (2014) Richard R. Furman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Deficiency of p110δ Isoform of the Phosphoinositide 3 Kinase Leads to Enhanced Resistance to Leishmania donovani
- (2014) Forough Khadem et al. PLoS Neglected Tropical Diseases
- Diminazene aceturate (Berenil) modulates LPS induced pro-inflammatory cytokine production by inhibiting phosphorylation of MAPKs and STAT proteins
- (2013) Shiby Kuriakose et al. Innate Immunity
- Clinical aspects of visceral leishmaniasis in HIV infection
- (2012) Joseph N. Jarvis et al. CURRENT OPINION IN INFECTIOUS DISEASES
- The phosphatidylinositol-3 kinase I inhibitor BKM120 induces cell death in B-chronic lymphocytic leukemia cellsin vitro
- (2012) Lilian Amrein et al. INTERNATIONAL JOURNAL OF CANCER
- Marginal Zone B Cells Regulate Antigen-Specific T Cell Responses during Infection
- (2012) R. Bankoti et al. JOURNAL OF IMMUNOLOGY
- Regulatory T Cells Suppress T Cell Activation at the Pathologic Site of Human Visceral Leishmaniasis
- (2012) Ambak K. Rai et al. PLoS One
- Involvement of CD4+ Foxp3+ Regulatory T Cells in Persistence of Leishmania donovani in the Liver of Alymphoplastic aly/aly Mice
- (2012) Saruda Tiwananthagorn et al. PLoS Neglected Tropical Diseases
- Effects of acutely inhibiting PI3K isoforms and mTOR on regulation of glucose metabolismin vivo
- (2011) Greg C. Smith et al. BIOCHEMICAL JOURNAL
- Myeloid Cell IL-10 Production in Response to Leishmania Involves Inactivation of Glycogen Synthase Kinase-3 Downstream of Phosphatidylinositol-3 Kinase
- (2011) D. Nandan et al. JOURNAL OF IMMUNOLOGY
- Amphotericin B inhibits entry of Leishmania donovani into primary macrophages
- (2010) Yamuna Devi Paila et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- The p110 Isoform of Phosphatidylinositol 3-Kinase Controls the Quality of Secondary Anti-Leishmania Immunity by Regulating Expansion and Effector Function of Memory T Cell Subsets
- (2010) D. Liu et al. JOURNAL OF IMMUNOLOGY
- Immunoactivation and immunopathogeny during active visceral leishmaniasis
- (2010) Hiro Goto et al. REVISTA DO INSTITUTO DE MEDICINA TROPICAL DE SAO PAULO
- In Vitro Susceptibilities of Leishmania donovani Promastigote and Amastigote Stages to Antileishmanial Reference Drugs: Practical Relevance of Stage-Specific Differences
- (2009) M. Vermeersch et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The p110 Isoform of Phosphatidylinositol 3-Kinase Controls Susceptibility to Leishmania major by Regulating Expansion and Tissue Homing of Regulatory T Cells
- (2009) D. Liu et al. JOURNAL OF IMMUNOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started